Michael Hebeisen Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Switzerland
1 protocol

Pedro Romero Ludwig Center for Cancer Research (LICR), Lausanne Branch, Switzerland
3 protocols

Daniel Speiser Ludwig Center for Cancer Research (LICR), Lausanne Branch, Switzerland
1 protocol

Petra Baumgaertner Ludwig Center for Cancer Research (LICR), Lausanne Branch, Switzerland
1 protocol

Nathalie Rufer
  • Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Switzerland
  • 1 Author merit
1 Protocol published
Chromium-51 (51Cr) Release Assay to Assess Human T Cells for Functional Avidity and Tumor Cell Recognition
Authors:  Petra Baumgaertner, Daniel E. Speiser, Pedro Romero, Nathalie Rufer and Michael Hebeisen, date: 08/20/2016, view: 6884, Q&A: 0
Cytotoxic CD8+ T cells are able to specifically recognize and kill target cells through specific interaction between their T cell receptors (TCRs) and small immunogenic peptides (antigens) presented by major histocompatibility complex ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.